Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells

被引:16
|
作者
Narla, RK [1 ]
Navara, C [1 ]
Sarquis, M [1 ]
Uckun, FM [1 ]
机构
[1] Parker Hughes Canc Ctr, Childrens Canc Grp, ALL Biol Reference Lab, St Paul, MN USA
关键词
TEL-AML1; translocation; PCR; ALL; chemotherapy; apoptosis;
D O I
10.3109/10428190109060352
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The TEL-AML1 fusion which results from a cryptic t(12;21) translocation is the most frequently occurring genetic abnormality in childhood acute lymphoblastic leukemia (ALL) and has been associated with an excellent treatment outcome. In the present study, we examined the FAS/BCL-2 expression profiles and chemosensitivity of primary leukemic cells from children with newly diagnosed t(12;21)TEL-AML1 fusion transcript-positive versus t(12;21)TEL-AML1 fusion transcript-negative standard risk ALL. TEL-AML1(+) ALL cells expressed higher levels of the pro-apoptotic protein Fas and lower levels of the anti-apoptotic protein Bcl2 than TEL-AML1(-) ALL cells, as determined by confocal laser scanning microscopy. TEL-AML1(+) ALL cells were more sensitive to the apoptosis-inducing effects of serum deprivation, dexamethasone and vincristine than TEL-AML1(-) ALL cells. This study provides novel mechanistic insights regarding the chemosensitivity of TEL-AML1(+) ALL cells and provides a cogent explanation for the excellent leukemia-free survival outcome of children with TEL-AML1(+) ALL treated on contemporary chemotherapy programs.
引用
收藏
页码:615 / +
页数:11
相关论文
共 50 条
  • [21] TEL-AML1 POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA-SINGLE CENTRE EXPERIENCE
    Kourti, M.
    Sgouropoulou, V.
    Athanassiadou, A.
    Papakonstantinou, E.
    Taparkou, A.
    Koliouskas, D.
    HAEMATOLOGICA, 2016, 101 : 664 - 664
  • [22] Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero
    Wiemels, JL
    Ford, AM
    Van Wering, ER
    Postma, A
    Greaves, M
    BLOOD, 1999, 94 (03) : 1057 - 1062
  • [23] Translocation ETS leukemia-acute myeloid leukemia 1 (TEL-AML1) gene fusion in childhood acute lymphoblastic leukemia
    Mulatsih, Sri
    Liang, Yeow
    Yeoh, Allen
    Sutaryo
    Sunarto
    PAEDIATRICA INDONESIANA, 2009, 49 (05) : 270 - 275
  • [24] Microclustering of TEL-AML1 translocation breakpoints in childhood acute lymphoblastic leukemia
    Wiemels, JL
    Alexander, FE
    Cazzaniga, G
    Biondi, A
    Mayer, SP
    Greaves, M
    GENES CHROMOSOMES & CANCER, 2000, 29 (03): : 219 - 228
  • [25] TEL-AML1 transgenic zebrafish model of acute lymphoblastic leukemia (ALL)
    Sabaawy, HE
    Azuma, M
    Embree, L
    Starost, MF
    Hickstein, DD
    BLOOD, 2005, 106 (11) : 34A - 34A
  • [26] Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21)
    Satake, N
    Kobayashi, H
    Tsunematsu, Y
    Kawasaki, H
    Horikoshi, Y
    Koizumi, S
    Kaneko, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) : 607 - 611
  • [27] Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia
    Uckun, FM
    Pallisgaard, N
    Hokland, P
    Navara, C
    Narla, R
    Gaynon, PS
    Sather, H
    Heerema, N
    LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) : 41 - 56
  • [28] THE T(12-21) OF ACUTE LYMPHOBLASTIC-LEUKEMIA RESULTS IN A TEL-AML1 GENE FUSION
    ROMANA, SP
    MAUCHAUFFE, M
    LECONIAT, M
    CHUMAKOV, I
    LEPASLIER, D
    BERGER, R
    BERNARD, OA
    BLOOD, 1995, 85 (12) : 3662 - 3670
  • [29] Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia
    Stams, WAG
    den Boer, ML
    Beverloo, HB
    Meijerink, JPP
    van Wering, ER
    Janka-Schaub, GE
    Pieters, R
    CLINICAL CANCER RESEARCH, 2005, 11 (08) : 2974 - 2980
  • [30] Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan
    Shih, LY
    Chou, TB
    Liang, DC
    Tzeng, YS
    Rubnitz, JE
    Downing, JR
    Pui, CH
    LEUKEMIA, 1996, 10 (09) : 1456 - 1458